Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:WCRX
Raised
Post IPO Valuation
Acquired byActavis
Price$8.5B
Date5/2013
TermsStock

General Information

Websitewcrx.com
CategoryBioTech
Phone441-292-0068
Employees1,200
Founded1968
Descriptionpharmaceutical company

Offices

HQ
100 Enterprise Drive
Rockaway, NJ, 07866
USA

People

Board Member

Tags

Warner Chilcott

Warner Chilcott is a leading mid-size specialty pharmaceutical company focused on developing, manufacturing and marketing and selling branded prescription pharmaceutical products in women’s healthcare and dermatology in the United States. We have established strong franchises in these two areas through our precision marketing techniques and specialty sales forces of over 400 representatives. We believe that our proven product development capabilities, coupled with our ability to execute acquisitions and in-licensing transactions and develop partnerships, will enable us to sustain and grow these franchises.

Warner Chilcott is proud to boast sales over $800 MM and one of the largest sales forces devoted to women’s healthcare and dermatology.

Recent Milestones

  • Handshake
    Warner Chilcott was acquired by Actavis for $8.5B. (5/20/13)
    Posted 5/20/13 at 9:13pm via actavis.com
  • Stock
    Went public with stock symbol NASDAQ:WCRX.
    Posted 5/20/13 at 9:14pm

Videos

Screenshots

Warner Chilcott screenshot
Above: Warner Chilcott Screenshot -- #1
Uploaded: 9/3/09

Stock Price

Sources

  1. Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company (ir.actavis.com) [edit]
Edit This Page
Last Edited 10/31/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy